Clarify Medical has announced that the Clarify Home Phototherapy System is now covered for TRICARE beneficiaries with psoriasis and eczema, effective immediately, the company said.
TRICARE is the health care program for uniformed service members, retirees, and their families, with approximately 10 million beneficiaries globally.
The Clarify System, which has been cleared by the FDA, is indicated for localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI).
Clarify Medical is a private San Diego-based medical device company focused on developing innovative technology, products and services that improve care for people with chronic skin conditions. Learn more at www.clarifymed.com.